California Stem Cell Agency 'Evaluating' Whether State Will Snag Some Cash in $1 Billion Deal
Above is the current pipeline for Neurona’s potential products as portrayed on the company website.
California’s stem cell agency says it is evaluating whether the more than $1 billion sale of Neurona Therapeutics, Inc., will bring any cash to the Golden State’s coffers.
In response to a question three days ago about the purchase of the South San Francisc…
